Insider · CIK 0001781117
Kelly MacDonald
Files at DVAX (DYNAVAX TECHNOLOGIES CORP). First filing -, latest -.
Kelly MacDonald files SEC Form 4 as CFO at DVAX (DYNAVAX TECHNOLOGIES CORP). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Kelly MacDonald has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 30 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | UTender of shares Common Stock | -60,204 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Common Stock - Performance Stock Units | +46,430 | - | - | 46,430 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Common Stock - Performance Stock Units | -46,430 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Common Stock - Performance Stock Units | +42,424 | - | - | 42,424 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Common Stock - Performance Stock Units | -42,424 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Stock Option (Right to Buy)derivative | -350,000 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Stock Option (Right to Buy)derivative | -90,500 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Stock Option (Right to Buy)derivative | -100,000 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Stock Option (Right to Buy)derivative | -65,000 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Stock Option (Right to Buy)derivative | -70,000 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Restricted Stock Unitsderivative | -15,476 | - | - | 0 | Feb 10, 2026 |
| Feb 10, 2026 | DVAX DYNAVAX TECHNOLOGIES CORP | DDisposition to issuer Restricted Stock Unitsderivative | -28,283 | - | - | 0 | Feb 10, 2026 |
| Dec 23, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Common Stock | +37,500 | - | - | 66,727 | Dec 29, 2025 |
| Dec 23, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +15,477 | - | - | 82,204 | Dec 29, 2025 |
| Dec 23, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +14,141 | - | - | 96,345 | Dec 29, 2025 |
| Dec 24, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -36,141 | $15.38 | $556k | 60,204 | Dec 29, 2025 |
| Dec 23, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -15,477 | - | - | 15,477 | Dec 29, 2025 |
| Dec 23, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -14,141 | - | - | 28,282 | Dec 29, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +15,477 | - | - | 34,202 | Feb 20, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -4,975 | $12.93 | $64k | 29,227 | Feb 20, 2025 |
| Feb 18, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -15,477 | - | - | 30,953 | Feb 20, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +16,000 | - | - | 24,043 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -5,318 | $12.69 | $67k | 18,725 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Restricted Stock Unitderivative | +16,000 | - | - | 16,000 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -16,000 | - | - | 0 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Stock Option (Right to Buy)derivative | +70,000 | - | - | 70,000 | Feb 18, 2025 |
| Feb 13, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | AGrant or award Restricted Stock Unitderivative | +42,424 | - | - | 42,424 | Feb 18, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Common Stock | +5,333 | - | - | 10,040 | Feb 12, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | FTax withholding Common Stock | -1,997 | $13.20 | $26k | 8,043 | Feb 12, 2025 |
| Feb 10, 2025 | DVAX DYNAVAX TECHNOLOGIES CORP | MOption exercise Restricted Stock Unitderivative | -5,333 | - | - | 0 | Feb 12, 2025 |
Questions about Kelly MacDonald
Answered from the filings on this page, as of the latest one.
Is Kelly MacDonald buying or selling?
Kelly MacDonald has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Kelly MacDonald's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Kelly MacDonald has 0.
Where does Kelly MacDonald file Form 4?
Kelly MacDonald has filed Form 4 at DVAX (DYNAVAX TECHNOLOGIES CORP) as SVP and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.